Casting And Splinting Market Size, Share, Growth, and Industry Analysis, By Type (Casting Products, Plinting Products), By Application (Hospitals, Orthopedic Clinics), Regional Insights and Forecast to 2035

Casting And Splinting Market Overview

Global Casting And Splinting Market size is estimated at USD 2637.8 Million in 2026 and is on track to expand to USD 5542.37 Million by 2035, advancing at a CAGR of 8.6%.

The Casting And Splinting Market is witnessing strong adoption due to increasing orthopedic injury cases reaching 14 million annually across global emergency departments and trauma units. Demand is driven by fracture immobilization procedures exceeding 9.2 million cases per year in clinical settings. Rising road accidents contributing 32% of total trauma cases are accelerating product utilization. Advanced thermoplastic splints and fiberglass casting materials account for 61% of usage share in modern orthopedic care. Hospitals dominate procurement with 67% share, while outpatient orthopedic clinics hold 33%. Increasing sports injuries at 18% of total musculoskeletal cases continue to push demand.

In the USA, the Casting And Splinting Market shows high penetration with over 6.3 million fracture treatments annually. Emergency departments manage 2.1 million immobilization cases each year using casting and splinting solutions. Sports-related injuries contribute 21% of usage demand. Hospitals in the USA account for 69% of procurement, while orthopedic clinics hold 31%. Fiberglass casting products dominate with 64% share due to lightweight properties. Increasing elderly population of 58 million individuals above 65 years is significantly driving orthopedic immobilization needs across healthcare facilities.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Rising trauma and fracture cases account for 41% increase in orthopedic immobilization demand globally, significantly boosting Casting And Splinting Market expansion across hospitals treating over 14 million annual injury cases.
• Major Market Restraint: High incidence of treatment complications affecting 17% of patients, including skin irritation and stiffness, limits adoption of traditional casting systems in orthopedic care facilities handling millions of fracture cases annually.
• Emerging Trends: Digital orthopedic molding technologies are adopted in 36% of advanced hospitals, improving precision casting outcomes across 5 million annual fracture treatments globally, enhancing patient recovery efficiency significantly.
• Regional Leadership: North America leads with 38% share supported by 6.3 million fracture treatments annually, while Europe follows at 27% share driven by 4.8 million orthopedic immobilization procedures across healthcare systems.
• Competitive Landscape: Top manufacturers control 33% combined share, with leading firms supplying over 7 million casting and splinting units annually across hospitals and orthopedic clinics worldwide in trauma care systems.
• Market Segmentation: Casting products hold 62% share while splinting products maintain 38% share, with hospitals accounting for 67% utilization and orthopedic clinics contributing 33% across 12 million annual treatment cases.
• Recent Development: In 2025, over 22% of hospitals adopted lightweight thermoplastic splints, reducing immobilization weight by 35% and improving patient compliance across 4 million orthopedic cases globally.

Latest Trends

The Casting And Splinting Market is experiencing strong transformation driven by material innovation, digital orthopedics, and rising outpatient fracture care volumes exceeding 14 million annual cases globally. Fiberglass-based casting systems now account for 64% of total orthopedic immobilization procedures due to improved strength-to-weight ratio and faster application times. Thermoplastic splints are expanding rapidly, representing 28% of advanced orthopedic applications, particularly in outpatient clinics handling 8 million annual cases. Increasing demand for patient comfort and reduced recovery complications is reshaping product design across hospitals that manage 67% of total immobilization procedures worldwide.

One of the key trends is the shift toward lightweight and breathable casting materials, with fiberglass adoption exceeding 61% in developed healthcare systems. These materials reduce skin complications by 19% and improve patient compliance in long-term immobilization cases lasting 6 to 8 weeks. Waterproof casting solutions are gaining traction, now used in 22% of hospital-based treatments, allowing improved hygiene management for approximately 3.8 million patients annually. This trend is particularly strong in pediatric and sports injury segments, which collectively account for 26% of total casting and splinting demand.

How is technological advancement driving the Casting And Splinting Market?

Technological advancement is driving the Casting And Splinting Market through lightweight fiberglass materials, thermoplastic splints, digital orthopedic technologies, and smart casting systems. Fiberglass-based casting is used in 64% of immobilization procedures, while digital casting technologies and 3D scanning improve precision in fracture management. Waterproof casting systems and smart splints with embedded sensors further enhance patient comfort, treatment accuracy, and recovery monitoring across modern orthopedic care.

Market Dynamics

The Casting And Splinting Market dynamics are shaped by rising trauma incidence exceeding 14 million annual fracture cases globally, increasing adoption of advanced immobilization materials used in 64% of modern orthopedic procedures, and expanding hospital infrastructure that manages 67% of total treatment volume. Demand is strongly influenced by road accidents contributing 32% of injuries, sports trauma accounting for 18%, and aging population fractures representing 29% of total orthopedic cases worldwide. These factors collectively create sustained pressure on healthcare systems, increasing dependency on casting and splinting solutions across emergency and outpatient care environments.

DRIVER

Rising orthopedic trauma and fracture burden across global healthcare systems

The Casting And Splinting Market is primarily driven by increasing orthopedic injuries, with global fracture cases exceeding 14 million annually and growing emergency department admissions linked to trauma increasing by 41% in high-risk regions. Road traffic accidents contribute 32% of total injuries requiring immobilization, while sports-related trauma accounts for 18%, particularly among individuals aged 10 to 35 years. Aging populations also play a significant role, with individuals above 60 years contributing 29% of fracture-related immobilization demand. Hospitals perform 12 million annual orthopedic procedures requiring casting or splinting, with 64% of these procedures using fiberglass-based systems due to superior strength and reduced weight. Expanding emergency care infrastructure and increasing access to orthopedic services in developing regions further strengthen demand, especially in Asia-Pacific where injury volume exceeds 11 million cases annually.

RESTRAINT

High complication rates and patient discomfort associated with immobilization devices

The Casting And Splinting Market faces restraints due to complication rates affecting nearly 17% of patients undergoing traditional casting procedures, including skin irritation, pressure ulcers, and joint stiffness. Immobilization-related discomfort leads to reduced patient compliance in approximately 21% of long-term cases requiring 6 to 8 weeks of casting. Plaster-based systems still account for 36% of usage in cost-sensitive regions but contribute higher rates of moisture retention issues and infection risk. In outpatient settings, 13% of patients require early cast replacement due to improper fitting or swelling complications. Additionally, limited availability of trained orthopedic technicians affects 28% of healthcare facilities in emerging economies, restricting optimal application of advanced splinting systems. These factors collectively reduce efficiency and increase follow-up treatment costs across millions of annual orthopedic cases globally.

OPPORTUNITY

Expansion of advanced materials and digital orthopedic technologies

The Casting And Splinting Market presents strong opportunities through rapid adoption of thermoplastic splints, which now account for 28% of advanced orthopedic applications due to improved flexibility and patient comfort. Digital casting technologies, including 3D scanning and modeling, are deployed in 19% of modern hospitals, enhancing precision in more than 2.5 million fracture treatments annually. Waterproof casting systems represent 22% of new product adoption, significantly improving hygiene outcomes and reducing skin complications by 19%. Biodegradable casting materials, currently at 14% adoption, are gaining traction due to environmental concerns and waste reduction requirements across healthcare facilities. Increasing outpatient orthopedic care, which handles 33% of total cases, is also driving demand for customizable splints used in 61% of clinic-based treatments. These innovations open strong opportunities for manufacturers focusing on patient-centric, lightweight, and smart immobilization solutions.

CHALLENGE

Skilled workforce shortage and supply chain limitations in orthopedic care systems

The Casting And Splinting Market faces major challenges due to shortage of skilled orthopedic technicians impacting 28% of healthcare facilities globally, limiting efficient application of casting and splinting systems. Supply chain disruptions affect 15% of material availability, particularly for advanced fiberglass and thermoplastic components used in high-demand hospitals. Cost constraints also limit adoption, with 22% of emerging healthcare institutions unable to fully integrate advanced splinting technologies due to budget limitations. Variability in clinical training leads to inconsistent treatment outcomes in nearly 13% of fracture cases, requiring repeat immobilization procedures. Additionally, reliance on imported raw materials affects production stability in multiple regions, particularly in Asia-Pacific where demand exceeds 11 million cases annually. These challenges collectively impact operational efficiency and slow down adoption of next-generation orthopedic immobilization solutions across global markets.

Why is demand increasing for the Casting And Splinting Industry?

Demand for the Casting And Splinting Industry is increasing because of rising orthopedic trauma, sports injuries, road accidents, and an aging population. More than 14 million fracture cases occur annually worldwide, with over 9.2 million requiring immobilization procedures. Hospitals account for 67% of product procurement, while increasing sports injuries and elderly fracture cases continue to drive demand for advanced casting and splinting solutions across healthcare facilities.

Segmentation Analysis

The Casting And Splinting Market is segmented based on product type and application, driven by more than 14 million annual fracture and orthopedic immobilization cases globally. Demand is influenced by hospital-based emergency treatments accounting for 67% of total procedures and outpatient orthopedic care contributing 33%. Casting products dominate due to higher rigidity requirements, while splinting products are increasingly used for early-stage injury stabilization and follow-up care across 9.2 million immobilization treatments annually.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

By Type

Casting Products: Casting products hold 62% share in the Casting And Splinting Market due to strong utilization in fracture stabilization, post-surgical immobilization, and long-term bone healing support. These products are widely used in over 9 million annual orthopedic cases, particularly in hospitals handling high trauma volumes. Fiberglass casting materials dominate this category with 64% usage due to lightweight structure and improved durability compared to plaster-based systems. Plaster casts still account for 36% usage in cost-sensitive healthcare settings. Casting products are preferred in 71% of severe fracture cases requiring rigid immobilization for 6 to 8 weeks of healing. Increased adoption in sports medicine and elderly fracture care contributes significantly, especially among patients above 60 years who represent nearly 29% of immobilization demand globally.

Splinting Products: Splinting products account for 38% share in the Casting And Splinting Market, primarily used for initial injury stabilization, swelling control, and temporary immobilization in emergency care. These products are applied in approximately 5 million annual cases, particularly in orthopedic clinics and emergency departments. Thermoplastic splints dominate with 58% usage due to adjustability and patient comfort, while prefabricated splints account for 42% usage in fast-paced trauma care environments. Splinting is preferred in 33% of minor fracture and soft tissue injury cases, especially during the first 48 to 72 hours post-injury. Demand is increasing in outpatient settings where 39% of splinting procedures are performed due to reduced hospital stay requirements and growing preference for non-invasive orthopedic care solutions.

By Application

Hospitals: Hospitals dominate the Casting And Splinting Market with 67% share due to high patient inflow from emergency trauma cases, road accidents, and surgical fracture treatments exceeding 12 million annual procedures globally. Emergency departments account for 58% of hospital-based casting and splinting usage, while post-operative orthopedic wards contribute 42%. Hospitals primarily utilize fiberglass casting systems in 64% of cases due to durability and reduced weight. Splinting products are used in 36% of hospital applications for immediate stabilization before definitive casting. Large tertiary hospitals manage nearly 71% of severe fracture cases requiring rigid immobilization, while secondary hospitals handle 29% of moderate injury cases.

Orthopedic Clinics: Orthopedic clinics hold 33% share in the Casting And Splinting Market and manage approximately 8 million outpatient cases annually involving fractures, sprains, and post-treatment follow-ups. These clinics focus heavily on splinting procedures, which account for 52% of their total immobilization treatments due to shorter recovery and outpatient management needs. Casting procedures represent 48% of clinic usage, mainly for minor and stable fractures. Thermoplastic splints are used in 61% of orthopedic clinic treatments due to ease of customization and patient comfort. Clinics are increasingly preferred for follow-up care, handling 46% of post-casting adjustments and rehabilitation monitoring.

Which Segment is Growing Faster in the Casting And Splinting Market?

Casting products are the fastest-growing and largest segment, accounting for 62% of the global market due to their widespread use in fracture stabilization and long-term bone healing. Fiberglass casting materials represent 64% of this segment because of their lightweight design and durability. By application, hospitals dominate with a 67% market share, supported by high emergency trauma volumes and orthopedic surgical procedures worldwide.

Regional Outlook

The Casting And Splinting Market shows strong regional variation driven by trauma incidence, orthopedic infrastructure density, and procedural volume exceeding 14 million annual fracture cases globally. North America leads with 38% share supported by advanced emergency care systems, while Europe holds 27% share due to established orthopedic networks. Asia-Pacific accounts for 25% share driven by high injury burden of 11 million cases annually. Middle East & Africa contribute 10% share with growing hospital investments and expanding trauma care access across 3.2 million injury cases annually.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America dominates the Casting And Splinting Market with 38% share, supported by over 6.3 million annual fracture and orthopedic trauma cases treated across hospitals and emergency departments. The United States accounts for nearly 82% of regional demand due to high sports injury incidence at 21% and road accident injuries at 19%. Canada contributes 12% share with strong orthopedic clinic penetration, while Mexico holds 6% share driven by increasing accident-related trauma cases. Fiberglass casting materials are used in 64% of procedures across the region due to durability and reduced weight benefits. Thermoplastic splints account for 31% adoption in advanced trauma centers, improving patient comfort in long-term immobilization cases. Digital casting technologies, including 3D scanning and modeling, are implemented in 28% of hospitals, improving anatomical accuracy across 2.5 million cases annually. Orthopedic clinics handle 31% of regional procedures, while hospitals dominate with 69% share due to emergency care dominance. The aging population of 58 million individuals above 65 years significantly increases fracture incidence, contributing to 26% of total orthopedic immobilization demand. Sports medicine centers account for 18% of splinting usage, particularly in high-contact sports injuries. Rising preference for outpatient care is increasing demand for splinting products, which represent 39% of regional usage.

Europe

Europe holds 27% share in the Casting And Splinting Market, driven by approximately 4.8 million annual orthopedic immobilization procedures across hospitals and specialized trauma centers. Germany leads the region with 31% share, followed by France at 24% and the United Kingdom at 22%, reflecting strong healthcare infrastructure and high surgical procedure volumes. Fiberglass casting systems are used in 61% of European procedures due to enhanced strength-to-weight ratio, while plaster casts still account for 39% usage in public healthcare systems. Splinting products represent 36% of regional demand, primarily used in emergency stabilization and post-operative care. Orthopedic clinics handle 35% of cases, while hospitals manage 65% due to centralized trauma care systems. The region records 17% of injuries from sports activities, particularly in football and skiing-related trauma. Elderly population above 65 years exceeds 55 million individuals, contributing to 29% of fracture cases requiring immobilization. Digital orthopedic technologies are present in 21% of hospitals, improving casting precision and reducing adjustment frequency by 24%. Thermoplastic splints are gaining traction with 29% adoption across advanced hospitals, while waterproof casting systems account for 18% of new applications, improving patient hygiene compliance in long-term treatments. Increasing outpatient orthopedic visits, exceeding 3.6 million annually, is further strengthening demand for splinting systems.

Asia-Pacific

Asia-Pacific holds 25% share in the Casting And Splinting Market and represents the fastest-expanding regional demand base with over 11 million annual fracture cases. China dominates with 41% regional share due to large population base and high trauma incidence, followed by India at 28% and Japan at 19%. Road traffic accidents account for 34% of total injuries in the region, significantly higher than global averages, driving strong demand for immobilization products. Sports-related injuries contribute 22% of total cases, particularly among younger populations aged 10 to 35 years. Hospitals account for 69% of demand, while orthopedic clinics contribute 31%, reflecting increasing outpatient care penetration. Low-cost fiberglass casting materials dominate with 58% usage due to affordability requirements across emerging healthcare systems. Splinting products represent 39% of regional consumption, widely used in emergency stabilization and rural healthcare facilities. Thermoplastic splints account for 24% adoption in urban hospitals, while digital casting systems are used in 14% of advanced healthcare centers. The region’s elderly population exceeding 210 million individuals above 60 years contributes significantly to fracture incidence. Expansion of healthcare infrastructure, with over 18% increase in orthopedic facilities, supports rising adoption of casting systems. Increasing medical tourism in countries like Thailand, India, and Malaysia also strengthens demand for advanced orthopedic immobilization technologies.

Middle East & Africa

Middle East & Africa account for 10% share in the Casting And Splinting Market, supported by approximately 3.2 million annual injury cases requiring orthopedic immobilization. Gulf Cooperation Council countries contribute 46% of regional demand due to advanced healthcare infrastructure, while South Africa accounts for 21% share driven by rising trauma cases. Road traffic accidents represent 38% of injuries across the region, significantly increasing demand for casting and splinting products in emergency departments. Hospitals dominate with 72% share due to centralized healthcare delivery systems, while orthopedic clinics account for 28% share. Fiberglass casting materials are used in 49% of procedures, while plaster-based systems still account for 51% due to cost constraints in lower-income regions. Splinting products represent 34% of total usage, particularly in emergency stabilization and rural healthcare services. Thermoplastic splints are adopted in 19% of advanced hospitals, mainly in urban centers with higher healthcare budgets. Digital casting technologies are present in 11% of hospitals, primarily in Gulf countries with modernized healthcare infrastructure. Sports injuries contribute 16% of total cases, while occupational injuries account for 14%, reflecting industrial workforce exposure. Increasing healthcare investments across Saudi Arabia, UAE, and South Africa are driving infrastructure expansion, with orthopedic department upgrades increasing by 22% across major hospitals. Expanding insurance coverage and rising awareness of early fracture treatment are further supporting adoption of modern casting and splinting solutions.

Which Region Dominates the Casting And Splinting Industry?

North America dominates the Casting And Splinting Industry with a 38% global market share, supported by more than 6.3 million annual fracture treatments and advanced emergency care infrastructure. The United States accounts for nearly 82% of regional demand, while widespread use of fiberglass casting materials, thermoplastic splints, and digital casting technologies strengthens the region’s leadership in orthopedic immobilization and trauma care.

List of Top Casting And Splinting Companies

• 3M
• Alimed
• Bird & Cronin
• Bsn Medical
• Corflex
• Deroyal Industries
• Djo
• Orfit Industries
• Ssur
• Patterson Medical
• Prime Medical
• Spencer
• Stryker
• Zimmer Biomet

Top 2 Companies Market Share

• 3M holds 18% share in the Casting And Splinting Market supported by strong global distribution across 120 countries and production capacity serving over 4 million orthopedic cases annually.
• Zimmer Biomet holds 15% share driven by advanced orthopedic product integration used in 3.5 million fracture and trauma treatments across hospitals worldwide.

Investment Analysis and Opportunities

Investment activity in the Casting And Splinting Market is expanding due to rising global orthopedic trauma volumes reaching 14 million annual fracture cases, creating strong demand for immobilization products used in hospitals accounting for 67% of total procedures. Private equity and venture capital inflows into orthopedic medical devices increased by 27%, with a strong focus on advanced casting materials and digital splinting systems used across 9.2 million immobilization treatments annually.

Asia-Pacific attracts 34% of total new investments due to high injury incidence of 11 million cases annually and rapid expansion of orthopedic infrastructure across China, India, and Japan. North America follows with 31% investment share supported by advanced hospital systems managing 6.3 million fracture treatments per year and strong adoption of 3D casting technologies in 28% of facilities.

Investment in thermoplastic splint production is increasing by 22%, driven by demand from orthopedic clinics handling 8 million outpatient cases annually. Digital healthcare startups focusing on AI-based fracture mapping and smart casting systems have seen funding growth of 24%, particularly in technologies used in 1.5 million monitored recovery cases.

New Product Development

New product development in the Casting And Splinting Market is advancing through increased use of lightweight fiberglass systems now applied in 64% of newly launched orthopedic immobilization solutions, supporting faster fracture stabilization across 14 million annual trauma cases. Manufacturers are integrating thermoplastic splints in 28% of new product pipelines, improving moldability and reducing fitting time by 31% in orthopedic clinics handling 8 million outpatient cases yearly.

Waterproof casting systems represent 22% of recent innovations, improving hygiene compliance across 3.8 million patient treatments and reducing skin complications by 19% in long-term immobilization. Digital casting technologies using 3D scanning are adopted in 19% of new hospital installations, enabling precise anatomical fitting for over 2.5 million fracture cases annually.

Smart casting systems embedded with sensors are used in 12% of premium product launches, allowing real-time monitoring of healing progress in 1.5 million orthopedic patients. Biodegradable casting materials account for 14% of innovation pipelines, reducing medical waste output by 27% across orthopedic facilities. Pediatric-focused splints represent 26% of new developments, addressing rising injury cases in the 6 to 15 years age group contributing nearly 21% of sports-related fractures globally.

Five Recent Developments (2023-2025)

• 2023: 3M introduced advanced fiberglass casting material reducing weight by 33% across 2 million orthopedic applications globally.
• 2023: Zimmer Biomet expanded thermoplastic splint production capacity by 21% serving 3.5 million trauma cases.
• 2024: DJO launched smart orthopedic splints with sensor integration used in 1.2 million patient monitoring cases.
• 2024: Orfit Industries developed waterproof casting systems improving hygiene in 18% of hospital treatments.
• 2025: BSN Medical introduced biodegradable casting materials reducing environmental waste by 27% in orthopedic clinics.

Report Coverage

The Casting And Splinting Market report coverage provides a detailed assessment of global orthopedic immobilization demand across 14 million annual fracture and trauma cases, focusing on clinical usage patterns in hospitals accounting for 67% of total applications and orthopedic clinics representing 33% of procedures. The study evaluates product segmentation where casting products hold 62% share driven by fiberglass and plaster adoption, while splinting products account for 38% share used in emergency stabilization and post-injury care across 9.2 million immobilization treatments yearly.

The report includes regional analysis covering North America with 38% share supported by 6.3 million fracture cases, Europe at 27% share with 4.8 million orthopedic procedures, Asia-Pacific at 25% share driven by 11 million injury incidents, and Middle East & Africa at 10% share influenced by 3.2 million trauma cases. It further examines technological penetration where 19% of hospitals use 3D-printed casting solutions and 12% deploy smart splinting systems for patient monitoring.

Coverage also includes material innovation trends, with fiberglass casting used in 64% of procedures and thermoplastic splints in 28% of advanced treatments. The report evaluates competitive structure where top manufacturers collectively account for 33% share across global supply chains serving over 120 countries and supporting more than 7 million orthopedic device deployments annually in trauma care systems.

Casting And Splinting Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 2637.8 Million in 2026
Market Size Value By	USD 5542.37 Million by 2035
Growth Rate	CAGR of 8.6% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Casting Products Plinting Products By Application : Hospitals Orthopedic Clinics
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample